Mentions
Extended reach
Total likes
Video views
AI synopsis
The comments reflect strong support for the study, such as calling it an 'Article of Interest' and sharing detailed citations, which indicate active interest and acknowledgment of its importance. The tone and word choices, like 'check out' and 'you should know,' convey enthusiasm and a belief in the study's potential impact on pediatric emergency care.
Most discussions acknowledge the value of the study, supporting its positive findings about antifibrinolytics in pediatric hemorrhage.
Participants show high curiosity, with multiple references encouraging others to read the article and highlighting its relevance.
Conversations include sharing of article details, referencing specific authors and studies, indicating moderate to deep engagement.
The discussions suggest that the findings could influence clinical practice and future research priorities.
Check out this APSA Article of Interest, You Should Know! Spinella, P et al Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage. 2022 doi: 10.1097/CCM.0000000000005383 Check out more on the App: https://t.co/1rFYXYJJuD https://t.co/Tc22t1SUSP
#ReSS22 Year in Review (Peds) Paper 9: Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study https://t.co/bHfvHiIBX2 https://t.co/auChT3Nv0T
Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study https://t.co/dLkfZxvLx8 https://t.co/1xZSWCDERx
Check out more work from @BloodNet_PALISI members including @PhilSpinellaMD on #antifibrinolytics in life threatening #bleeding #PedsICU https://t.co/8uPLnI3lpl
RT @BloodNet_PALISI: Check out more work from @BloodNet_PALISI members including @PhilSpinellaMD on #antifibrinolytics in life threatening…
RT @StayCurrentMD: Check out this APSA Article of Interest, You Should Know! Spinella, P et al Use of Antifibrinolytics in Pediatric Life…
This study explores antifibrinolytic drugs like tranexamic acid in children with severe bleeding, showing a significant reduction in early mortality and potential benefits in managing pediatric hemorrhage.
This episode reviews the use of antifibrinolytic drugs like tranexamic acid in children with severe bleeding. The study shows these medications are associated with reduced mortality within 6 hours of bleeding…
#ReSS22 Year in Review (Peds) Paper 9: Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study https://t.co/bHfvHiIBX2 https://t.co/auChT3Nv0T
RT @StayCurrentMD: Check out this APSA Article of Interest, You Should Know! Spinella, P et al Use of Antifibrinolytics in Pediatric Life…
RT @StayCurrentMD: Check out this APSA Article of Interest, You Should Know! Spinella, P et al Use of Antifibrinolytics in Pediatric Life…
Check out this APSA Article of Interest, You Should Know! Spinella, P et al Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage. 2022 doi: 10.1097/CCM.0000000000005383 Check out more on the App: https://t.co/1rFYXYJJuD https://t.co/Tc22t1SUSP
RT @PEMUpdates: Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study https://t.…
Use of Antifibrinolytics in Pediatric Life-Threatening Hemorrhage: A Prospective Observational Multicenter Study https://t.co/dLkfZxvLx8 https://t.co/1xZSWCDERx
RT @BloodNet_PALISI: Check out more work from @BloodNet_PALISI members including @PhilSpinellaMD on #antifibrinolytics in life threatening…
RT @BloodNet_PALISI: Check out more work from @BloodNet_PALISI members including @PhilSpinellaMD on #antifibrinolytics in life threatening…
Check out more work from @BloodNet_PALISI members including @PhilSpinellaMD on #antifibrinolytics in life threatening #bleeding #PedsICU https://t.co/8uPLnI3lpl